Elie Dolgin | Jul 1, 2009 | 6 min read
By Elie Dolgin Success with iPSCs The nascent science still has many stumbling blocks to step over before companies can reap the rewards of reprogramming. iPS cells Courtesy of California Institute for Regenerative Medicine A decade ago, the United States granted a series of patents that some say changed the embryonic stem cell (ESC) field forever. The Wisconsin Alumni Research Foundation (WARF) received three broad patent